1 / 11

Moving Forward – Planning for 2008 - 2009 Dr. Barbara Laughon

Moving Forward – Planning for 2008 - 2009 Dr. Barbara Laughon Secretary, Working Group on New TB Drugs. Proposed Biennial Work Plan 2008-2009. Priority Area 1: Support Global R&D for New Drugs Promote research coordination to advance the global TB drug pipeline .

emele
Download Presentation

Moving Forward – Planning for 2008 - 2009 Dr. Barbara Laughon

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Moving Forward – Planning for 2008 - 2009 Dr. Barbara Laughon Secretary, Working Group on New TB Drugs

  2. Proposed Biennial Work Plan 2008-2009 Priority Area 1: Support Global R&D for New Drugs • Promote research coordination to advance the global TB drug pipeline. Convene Annual Symposia at IUATLD on TB drug development; Publish R&D activity mapping project. Update annually. • Support development of clinical trial site capacity. Assess funding needs for clinical trial site capacity building.

  3. Proposed Biennial Work Plan 2008-2009 Priority Area 1 (Continued): Support Global R&D for New Drugs • Promote development of biomarkers, surrogate endpoints, animal models. Publish contracted review on the state of the art of biomarkers; Organize/co-sponsor a symposium on these topics. • Identify strategies to evaluate new drugs for MDR- and XDR-TB Sponsor and help organize meetings of the MDR/XDR Task Force; Sponsor publication of MDR/XDR Task Force documents; Support other activities of the MDR/XDR Task Force.

  4. Proposed Biennial Work Plan 2008-2009 Priority Area 2: Promote harmonized regulatory guidelines for TB and MDR-TB Drug Development Organize and co-sponsor Open Forum on key regulatory issues – New Delhi May 5-6, 2008 Priority Area 3: Promote engagement with affected-community representatives Sponsor travel to annual meetings, symposia, Open Fora; Provide support and training to facilitate participation in meetings and WGND activities.

  5. Proposed Biennial Work Plan 2008-2009 Priority Area 4: Maintain communication and collaboration Convene annual WGND meetings; participate in Partnership meetings; Update the Strategic Plan; Convene a core group to oversee implementation of the Strategic Plan; Support the activities of the Retooling Task Force; Publications: e.g. brochure, newsletter, annual reports WG website: update drug projects information

  6. Global R&D Activity Update

  7. Working Group Mission Translational Basic Research Projects

  8. Working Group Mission Discovery Stage Projects (page 1 of 2)

  9. Working Group Mission Discovery Stage Projects (continued)

  10. Working Group Mission Preclinical Stage Projects

  11. Clinical Stage Projects Working Group Mission

More Related